Thursday, June 30, 2005-- Archer Daniels Midland Company’s (ADM) Identity Preserved Non-GM Program for Vitamin E, Mixed Tocopherols, and Phytosterol Products has received independent confirmation of compliance with European regulations concerning traceability and labeling of Genetically Modified Organisms by Eurofins - GeneScan, the world leader in GMO detection, Non-GM verification and certification.
This validation confirms that the above mentioned products have been manufactured through a Non-GM program that has implemented measures to effectively control the presence of GM material and is being maintained in accordance with the European requirements for labeling and traceability.
As part of its Identity Preservation Verification program, Eurofins-GeneScan conducts audits to provide independent assessments of the risk management practices of companies that manufacture, handle, or store Non-GM products. To obtain a satisfactory assessment, a company must demonstrate its commitment to achieving high operational standards and maintaining organizational and physical processes to ensure that quality system objectives are being met.
Some of the key criteria used in evaluation are the appropriate implementation of systematic risk assessments, documentation, training procedures, adverse event management, segregation measures, verification of suppliers, traceability, sampling protocols, and analysis. This year, ADM’s IP Non-GM Program underwent comprehensive audits that included the review of program specific documentation encompassing all procedures from the sourcing of Non-GM grain to the manufacture of the final product. In addition, Eurofins-GeneScan also conducted on-site assessments of facilities involved in the production of Deodorizer Distillate as well as Vitamin E, mixed tocopherols, and phytosterols. The scope of this program is international as it includes grain suppliers, crushing facilities, and end production facilities located in South America, Europe as well as the US.
The successful verification of this system demonstrates that the Non-GM program is operating in a sound manner consistent with relevant quality standards and shows ADM’s commitment to its Non- GM customer base. This follows last year’s successful program certification by Eurofins-GeneScan of ADM’s Documented IP Program for Soy Ingredients that covers the manufacture of flours, concentrates, isolates, isoflavones, and other products derived from Identity Preserved Non- GM soybeans.
Archer Daniels Midland Company (ADM) is a world leader in agricultural processing. ADM is one of the world's largest processors of soybeans, corn, wheat and cocoa. ADM is also a leader in the production of soy meal and oil, ethanol, corn sweeteners and flour. In addition, ADM produces value-added food and feed ingredients. Headquartered in Decatur, Illinois, ADM has over 26,000 employees, more than 250 processing plants and net sales for the fiscal year ended June 30, 2004 of $36.2 billion. Additional information can be found on ADM's Web site at
Eurofins GeneScan Inc., located in Metairie, LA. is a subsidiary of the Eurofins Scientific, S.A. Eurofins-GeneScan operates in the area of quality and identity control of food and animal feed. The focus of these activities is the detection of allergens and detection of genetically modified organisms (GMO) in seeds, agricultural commodities, semi-finishedand finished products.
The company meets its customers’ global requirements by operating its own analysis laboratories in Europe, North and South America and by establishing networks of strategic partners and licensees.
In addition to carrying out service analyses Eurofins-GeneScan also offers the corresponding diagnostics kits to third party laboratories. The Group’s portfolio also includes design, implementation and certification of customized control programs and identity preservation systems along the entire production chain.
Eurofins Scientific is a life sciences company operating internationally to provide a comprehensive range of analytical support services drawing on the latest developments in biotechnology. The Group specializes in delivering analytical testing services to clients from a wide range of industries including the pharmaceutical, food and environmental sectors. The Eurofins Group aims to become a world market leader in this field of applied life sciences and is pursuing a dynamic expansion strategy to improve both its technology portfolio and its geographic reach. Through R&D, inlicensing and acquisitions, the Group draws on the latest developments in the field to offer its clients unparalleled analytical solutions.
With over 2,000 staff in more than 40 laboratories across 15 countries and a portfolio of over 10,000 analytical methods for proving the authenticity, origin, safety, identity, and purity of biological substances, Eurofins Scientific is already a leading global provider of bioanalytical services. The Group is committed to supporting its clients’ objectives of ensuring that their products reach the best possible quality and safety levels in all markets in which they operate.
Eurofins Scientific intends to continue to develop, acquire or license the most comprehensive range of state-of-the-art analytical technologies in order to support its clients’ increasingly stringent quality and safety standards and the demands of regulatory authorities around the world.
The shares of Eurofins Scientific are listed on Euronext in Paris (ISIN FR0000038259) and on the Frankfurt (WKN 910251) Stock Exchange (Reuters EUFI.LN, Bloomberg ERSC FP, ESF, EUFI.DE).